Gastro-intestinal transit of a multiple-unit formulation (metoprolol CR/ZOK) and a non-disintegrating tablet with the emphasis on colon

International Journal of Pharmaceutics

Volumn 140, Issue 2, 1996, Pages 229-235

  Abrahamsson, Bertil ^a   Alpsten, Magne ^b   Jonsson, Ulf E ^a   Lundberg, P J ^a   Sandberg, Anders ^a   Sundgren, Mats ^a   Svenheden, Agneta ^a   Tölli, Jukka ^b  

^a ASTRAZENECA R AND D   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Gamma scintigraphy; Gastrointestinal transit; Metoprolol; Pellets

Indexed keywords

METOPROLOL TARTRATE; PLACEBO; TOPROLOL XL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISSOLUTION; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG FORMULATION; GAMMA SCINTIGRAPHY; GASTROINTESTINAL TRANSIT; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; STOMACH EMPTYING; TABLET; VOLUNTEER;

EID: 0030606882     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-5173(96)04604-2     Document Type: Article

References (20)

1. Alpsten, M., Bogentoft, C. and Jonsson, U.E., A profile scanning scintigraphy system for in vivo studies of solid dosage forms. S.T.P. Pharma. 1 (1985) 1043-1052.
2. Christensen, F.N., Davis, S.S., Hardy, J.G., Taylor, M.J., Whalley, D.R. and Wilson, C.G., The use of gamma scintigraphy to follow the gastrointestinal transit of pharmaceutical formulations. J. Pharm. Pharmacol., 37 (1985) 91-95.
3. Clarke, G.M., Newton, J.M. and Short, M.D., Gastro-intestinal transit of pellets of differing size and density. Int. J. Pharm., 100 (1993) 81-92.
4. Coupe, A.J., Davis, S.S., Evans, D.F. and Wilding, I.R., Do pellet formulations empty from the stomach with food? Int. J. Pharm., 92 (1993) 167-175.
5. Davis, S.S., Hardy, J.G., Taylor, M.J., Whalley, D.R. and Wilson, C.G. The effect of food on the gastro-intestinal transit of pellets and an osmotic device (Osmet). Int. J. Pharm., 21 (1984) 331-340.
6. Davis, S.S., Hardy, J.G. and Fara, J.W., Transit of pharmaceutical dosage forms through the small intestine, Gut, 27 (1986) 886-892.
7. Ervik, M., Kylberg-Hanssen, K. and Johansson, L., Determination of metoprolol in plasma and urine using high-resolution gaschromatography and electron-capture detection. J. Chromatogr., 381 (1986) 168-174.
8. Hardy, J.G., Wilson, C.G. and Wood, E., Drug delivery to proximal colon. J. Pharm. Pharmacol., 37 (1985) 874-877.
9. Kendall, M.J., Maxwell, S.R., Sandberg, A. and Westergren, G., Controlled release metoprolol. Clinical pharmacokinetic and therapeutic implications. Clin. Pharamcokinet., 5 (1991) 319-330.
10. Podczeck, F., Newton, J.M. and Yuen, K.H. The description of the gastrointestinal transit of pellets assessed by gamma scintigraphy using statistical moments. Pharm. Res., 12 (1995) 376-379.
11. 51Cr labelled MUPS for Gastro-intestinal transit study, produced in small scale. Proc. Int. Symp. Control. Rel. Bioact. Mater., 15 (1988) 360-361.
12. Proano, M., Camelleri, M., Phillips, S.F., Brown, M.L. and Thomforde, G.M. Transit of solids through the human colon: regional quantification in the unprepared bowel. Am. J. Physiol. (Gastrointest Liver Physiol.), 258 (1990) G856-G862.
13. Sarna, S.K. Physiology and pathophysiology of colonic motor activity. Part two of two. Digest. Dis. Sci., 36 (1991) 998-1018.
14. Sandberg, A., Abrahamsson, B., Svenheden, A., Olofsson, B. and Bergstrand R., Steady state bioavailability and day-to-day variability of a multiple-unit (CR ZOK) and a single-unit (OROS) delivery system of metoprolol after once daily dosing. Pharm. Res., 10 (1993) 28-33.
15. Sandberg, A., Ragnarsson, G., Jonsson, U.E. and Sjögren, J., Design of a new multiple-unit controlled-release formulation of metoprolol-metoprolol CR. Eur. J. Clin. Pharmacol., 33 (Suppl.) (1988) S3-S7.
16. Sandberg, A., Abrahamsson, B. and Sjögren, J., Influence of dis-solution rate or the extent and rate of bioavailability of metoprolol. Int. J. Pharm., 68 (1991) 167-177.
17. Steed, K.P., Wilson, C.G. and Washington, N., Drug delivery to the large intestine. In Wilson, C.G. and Washington, N. (Eds.). Physiological Pharmaceutics: Biological Barriers to Drug Absorption. Elis Horwood limited, Chichester, 1989, pp. 91-108.
18. von Hattingberg, H.M., Moment analysis in vivo and in vitro, Methods Find. Exp. Clin. Pharmacol., 6 (1984) 589-595.
19. Wagner, J.G. and Nelson, W., Per cent absorbed time plots derived from blood level and or urinary excretion data. J. Pharm. Sci., 52 (1963) 610-611.
20. Watts, P.J., Barrow, L., Steed, K.P., Wilson, C.G., Spiller, R.C., Melia, C.D. and Davies, M.C., The transit rate of different-sized model dosage forms through the human colon and the effect of lactose-induced catharsis. Int. J. Pharm., 87 (1992) 215-221.